Literature DB >> 21519466

How can we manage hyperlipidemia and avoid rhabdomyolysis in transplant patients?

Joseph M Kahwaji, Ryszard R Dudek.   

Abstract

Entities:  

Year:  2006        PMID： 21519466      PMCID： PMC3078775          DOI： 10.7812/TPP/06-018

Source DB:  PubMed          Journal:  Perm J        ISSN： 1552-5767


× No keyword cloud information.
  16 in total

Review 1.  Hyperlipidemia in solid organ transplantation.

Authors:  J A Kobashigawa; B L Kasiske
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

2.  Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients.

Authors:  W Mück; I Mai; L Fritsche; K Ochmann; G Rohde; S Unger; A Johne; S Bauer; K Budde; I Roots; H H Neumayer; J Kuhlmann
Journal:  Clin Pharmacol Ther       Date:  1999-03       Impact factor: 6.875

3.  Low-dose lovastatin safely lowers cholesterol after cardiac transplantation.

Authors:  J A Kobashigawa; F L Murphy; L W Stevenson; J D Moriguchi; N Kawata; P Kamjoo; E Brownfield; J Wilmarth; L Leonard; C Chuck
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

Review 4.  Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.

Authors:  Vincent Launay-Vacher; Hassane Izzedine; Gilbert Deray
Journal:  Int J Cardiol       Date:  2005-05-11       Impact factor: 4.164

Review 5.  Efficacy and safety of rosuvastatin in treatment of dyslipidemia.

Authors:  James M McKenney
Journal:  Am J Health Syst Pharm       Date:  2005-05-15       Impact factor: 2.637

6.  Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine.

Authors:  R Goldberg; D Roth
Journal:  Transplantation       Date:  1996-12-15       Impact factor: 4.939

Review 7.  Hyperlipidemia and cardiovascular disease after organ transplantation.

Authors:  Z A Massy
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

8.  A prospective study on treatment of hypercholesterolemia with lovastatin in renal transplant patients receiving cyclosporine.

Authors:  A K Cheung; G A DeVault; M C Gregory
Journal:  J Am Soc Nephrol       Date:  1993-06       Impact factor: 10.121

9.  A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.

Authors:  R B Goldberg; D Roth
Journal:  Am J Cardiol       Date:  1995-07-13       Impact factor: 2.778

10.  Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.

Authors:  B Kasiske; F G Cosio; J Beto; K Bolton; B M Chavers; R Grimm; A Levin; B Masri; R Parekh; C Wanner; D C Wheeler; P W F Wilson
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086
View more
  1 in total

Review 1.  Dyslipidemia in patients with chronic kidney disease: etiology and management.

Authors:  Ivana Mikolasevic; Marta Žutelija; Vojko Mavrinac; Lidija Orlic
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.